IFFIm Board meets in Geneva, plans role in global pandemic preparedness

IFFIm Board meets in Geneva, plans role in global pandemic preparedness

14 July 2022

IFFIm’s Board of Directors convened at Gavi headquarters in Geneva the week of 20 June.

IFFIm’s Board of Directors convened at Gavi headquarters in Geneva the week of 20 June. Over five days of meetings and events, they charted future priorities, acknowledging the realities confronting Gavi’s work in an uncertain world, and confirmed their strong interest in IFFIm playing a role in the future global health architecture for pandemic preparedness and response. The board was pleased to have Gavi Vice-Chair Sarah Goulding attend their meeting as an observer.

Discussing IFFIm’s impact on global health, Gavi CEO Dr Seth Berkley said that throughout 2020 and 2021, Gavi was able to leverage IFFIm’s capability to provide timely funding at scale, disbursing more than US$ 800 million in IFFIm funds for immunisation programmes and US$ 211 in funding for COVAX in those two years alone. (Gavi has disbursed more than US$ 4.1 million in IFFIm funding for immunisation programmes since IFFIm’s inception in 2006.)

He added that IFFIm will remain a key resource for Gavi over the 2023-2025 period with IFFIm support expected to be close to US$ 3.3 billion for core programmes, as well as additional frontloading proceeds for the COVAX AMC.

Dr Berkley also congratulated Doris Herrera-Pol and Helge Weiner-Trapness on their reappointments as members of the IFFIm Board of Directors and expressed his appreciation for their continuing commitment to Gavi’s mission. 

While in Geneva, IFFIm board members participated in Gavi’s board meeting as observers, with IFFIm Board Chair Ken Lay presenting an update on IFFIm.

The Gavi Board announced several decisions, including driving a renewed focus on vaccine equity, providing greater support for fragile and conflict countries and integrating COVAX into core routine immunisation services.

In the face of conflicts and humanitarian crises, the Gavi Board also approved a revision to their fragility, emergencies and displaced populations policy because, said Dr Berkley, “ensuring access for all displaced communities is the true test of our resolve for vaccine equity.” 

Speaking about the outcomes of the June gathering, Gavi Board Chair José Manuel Barroso added, "Gavi’s Board has provided unequivocal backing to the organisation as it strives to restore and maintain routine immunisation, reach zero dose children and help bring the current and future pandemics under control."